Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Ascendiant Capital Maintains Buy on Envoy Medical, Raises Price Target to $8.75

Author: Benzinga Newsdesk | September 03, 2024 05:38am
Ascendiant Capital analyst Edward Woo maintains Envoy Medical (NASDAQ:COCH) with a Buy and raises the price target from $8.5 to $8.75.

Posted In: COCH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist